Explore Our Biomarker Menu

Biomarker:

EGF (plasma)

Biological or Clinical Significance:

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein[2] with 53 amino acid residues and three intramolecular disulfide bonds. EGF was originally described independently as a secreted peptide found in the submaxillary glands of mice and in human urine. Initially, human EGF was known as urogastrone.

Epidermal growth factor can be found in urine, saliva, milk, and plasma. The production of epidermal growth factor has been found to be stimulated by testosterone. EGF acts by binding with high affinity to epidermal growth factor receptor (EGFR) on the cell surface. This stimulates ligand-induced dimerization,[8] activating the intrinsic protein-tyrosine kinase activity of the receptor.

References:

Analyte:

EGF (plasma)

Matrix:

Status:

Experienced Running

Sensitivity-LLOQ:

2.44 pg/mL

Sensitivity-ULOQ:

10,000 pg/mL

platform

Luminex, MSD-ECL

Required Sample Volume

50 µL/well

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.